Skip to content

Modulari-T

YC W23 · Active · We teach your immune system to attack and cure cancer

Competitors

Adjacent

Also from W23

All of W23

About Modulari-T

Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise. Modulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue. Modulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.

YC batch
W23 · Winter 2023
Status, per YC
Active
Category
Other
Team size
4
Location
Montreal, QC, Canada; San Francisco, CA, USA
Checked
33m ago

YC tags: Gene Therapy, Cell Therapy, Synthetic Biology, Biotech, Oncology

Modulari-T in W23: 274 companies, 68% AI

Modulari-T: questions

Which YC batch was Modulari-T in?

Modulari-T was in Y Combinator's Winter 2023 batch (W23).

Is Modulari-T still active?

Y Combinator lists Modulari-T as active.

Where is Modulari-T based?

Modulari-T lists Montreal, QC, Canada; San Francisco, CA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.